18F-FET PET Imaging in Differentiating Glioma Progression from Treatment-Related Changes: A Single-Center Experience
Conclusion: In our neurooncology department, the diagnostic performance of 18F-FET PET was convincing but slightly inferior to that of previous reports.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Maurer, G. D., Brucker, D. P., Stoffels, G., Filipski, K., Filss, C. P., Mottaghy, F. M., Galldiks, N., Steinbach, J. P., Hattingen, E., Langen, K.-J. Tags: Clinical Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Glioma | International Medicine & Public Health | Neurology | Nuclear Medicine | WHO